Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

Author： Bozikas V.P.   Papakosta M.   Niopas I.   Karavatos A.   Mirtsou-Fidani V.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.14, Iss.1, 2004-01, pp. : 39-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients

By Doude van Troostwijk L.J.A.E.   Koopmans R.P.   Vermeulen H.D.B.   Guchelaar H.-J.  

European Journal of Pharmaceutical Sciences, Vol. 20, Iss. 4, 2003-12 ,pp. : 451-457

Elsevier

Access to resources Recommend Favorite

Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population

By Gunes Arzu   Ozbey Gul   Vural Elif Hilal   Uluoglu Canan   Scordo Maria Gabriella   Zengil Hakan   Dahl Marja-Liisa  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 769-778

Future Medicine

Access to resources Recommend Favorite

Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity

By Neafsey Pat  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 362-388

Taylor & Francis Ltd

Access to resources Recommend Favorite

Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe

By  

Current Drug Metabolism, Vol. 13, Iss. 5, 2012-05 ,pp. : 667-678

Bentham Science Publishers

Access to resources Recommend Favorite

Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia

By Perera Vidya  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1115-1137

Informa Healthcare

Access to resources Recommend Favorite